Related Experiment Videos

An in vitro model for disease-specific immunotherapy in myasthenia gravis using soluble MHC class II bound to

M W Nicolle1, A Vincent, S Sharma

  • 1Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, United Kingdom.

Annals of the New York Academy of Sciences
|June 21, 1993
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos